Lenti-D

elivaldogene autotemcel · Genetix Biotherapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lenti-D, covering 2022-04-25 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product